{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:23:21Z","timestamp":1762917801615},"reference-count":35,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7595","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T22:13:49Z","timestamp":1500070429000},"page":"1831-1837","source":"Crossref","is-referenced-by-count":12,"title":["Dermatomyositis Induced by Hepatitis B Virus-related Hepatocellular Carcinoma: A Case Report and Review of the Literature"],"prefix":"10.2169","volume":"56","author":[{"given":"Jen-Wei","family":"Chou","sequence":"first","affiliation":[{"name":"School of Medicine, China Medical University, Taiwan"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, China Medical University Hospital, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Lan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Education, China Medical University Hospital, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-Sheng","family":"Cheng","sequence":"additional","affiliation":[{"name":"School of Medicine, China Medical University, Taiwan"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, China Medical University Hospital, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Yuan","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Medicine, China Medical University, Taiwan"},{"name":"Department of Dermatology, China Medical University Hospital, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teressa","family":"Reanne Ju","sequence":"additional","affiliation":[{"name":"Department of Education, China Medical University Hospital, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Kao LL, Chung L, Fiorentino DF. Pathogenesis of dermatomyositis: role of cytokines and interferon. Curr Rheumatol Rep 13: 225-232, 2011."},{"key":"2","unstructured":"2. Andras C, Ponyi A, Constantin T, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 35: 438-444, 2008."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tiniakou E, Mammen AL. Idiopathic inflammatory myopathies and malignancy: a comprehensive review. Clin Rev Allergy Immunol 2015 Oct 1 [Epub ahead of print].","DOI":"10.1007\/s12016-015-8511-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cheng TI, Tsou MH, Yang PS, Sung SM, Chuang VP, Sung JL. Dermatomyositis and erythrocytosis associated with hepatocellular carcinoma. J Gastroenterol Hepatol 17: 1239-1240, 2002.","DOI":"10.1046\/j.1440-1746.2002.t01-1-02851.x"},{"key":"5","unstructured":"5. Gomez A, Solans R, Simeon CP, et al. Dermatomyositis, hepatocarcinoma, and hepatitis C: comment on the article by Weidensaul et al. Arthritis Rheum 40: 394-395, 1997."},{"key":"6","unstructured":"6. Gray RG, Altman RD, Gottlieb NL. Aberrant serum enzyme patterns in dermatomyositis associated with hepatoma. J Rheumatol 3: 227-232, 1976."},{"key":"7","first-page":"1425","volume":"47","author":"K Hasegawa","year":"2000","unstructured":"7. Hasegawa K, Uesugi H, Kubota K, et al. Polymyositis as a paraneoplastic manifestation of hepatocellular carcinoma. Hepatogastroenterology 47: 1425-1427, 2000.","journal-title":"Hepatogastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0172-6390","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Horie Y, Yamada M, Nakai K, et al. Combined hepatocellular-cholangiocarcinoma associated with dermatomyositis. J Gastroenterol Hepatol 4: 101-104, 1989.","DOI":"10.1111\/j.1440-1746.1989.tb00812.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Inuzuka M, Tomita K, Tokura Y, Takigawa M. Acquired ichthyosis associated with dermatomyositis in a patient with hepatocellular carcinoma. Br J Dermatol 144: 416-417, 2001.","DOI":"10.1046\/j.1365-2133.2001.04040.x"},{"key":"10","unstructured":"10. Kee KM, Wang JH, Lee CM, Changchien CS, Eng HL. Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma. Chang Gung Med J 27: 834-839, 2004."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kee SJ, Kim TJ, Lee SJ, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Rheumatol Int 29: 595-599, 2009.","DOI":"10.1007\/s00296-008-0718-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kim MJ, Kim JA, Sung MS, Min JK. Hepatocellular carcinoma, polymyositis, rhabdomyolysis, and acute renal failure. J Korean Med Sci 19: 891-894, 2004.","DOI":"10.3346\/jkms.2004.19.6.891"},{"key":"13","unstructured":"13. Kishore D, Khurana V, Raj A, Gambhir IS, Diwaker A. Hepatocellular carcinoma presenting as polymyositis: a paraneoplastic syndrome. Ann Saudi Med 31: 533-535, 2011."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Leaute-Labreze C, Perel Y, Taieb A. Childhood dermatomyositis associated with hepatocarcinoma. N Engl J Med 333: 1083, 1995.","DOI":"10.1056\/NEJM199510193331615"},{"key":"15","unstructured":"15. Tekaya R, Abdelghni K, Abdelmoula L, Ben Hadj Yahia C, Chaabouni L, Zouari R. Hepatocellular carcinoma with polymyositis as an initial symptom: a case report. Acta Clin Belg 66: 53-54, 2011."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Thanapirom K, Aniwan S, Treeprasertsuk S. Polymyositis associated with hepatitis B virus cirrhosis and advanced hepatocellular carcinoma. ACG Case Rep J 1: 167-169, 2014.","DOI":"10.14309\/crj.2014.39"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Toshikuni N, Torigoe R, Mitsunaga M, Omoto A, Nakashima K. Dermatomyositis associated with hepatocellular carcinoma in an elderly female patient with hepatitis C virus-related liver cirrhosis. World J Gastroenterol 12: 1641-1644, 2006.","DOI":"10.3748\/wjg.v12.i10.1641"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yang SY, Cha BK, Kim G, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Korean J Intern Med 29: 231-235, 2014.","DOI":"10.3904\/kjim.2014.29.2.231"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326: 363-367, 1992.","DOI":"10.1056\/NEJM199202063260602"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Huang H, Hu XF, Zhao FH, Garland SM, Bhatla N, Qiao YL. Estimation of cancer burden attributable to infection in Asia. J Epidemiol 25: 626-638, 2015.","DOI":"10.2188\/jea.JE20140215"},{"key":"21","unstructured":"21. Shlomai A, de Jong YP, Rice CM. Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol 26: 78-88, 2014."},{"key":"22","unstructured":"22. Birrer RB, Birrer D, Klavins JV. Hepatocellular carcinoma and hepatitis virus. Ann Clin Lab Sci 33: 39-54, 2003."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Qu Q, Wang S, Chen S, Zhou L, Rui JA. Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma. Am Surg 80: 191-196, 2014.","DOI":"10.1177\/000313481408000230"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Vautravers C, Rat P, Cercueil JP, Moreau T, Horiot JC, Chauffert B. Hepatocellular carcinoma presenting as paraneoplastic myasthenia gravis. Eur J Intern Med 19: e86-e87, 2008.","DOI":"10.1016\/j.ejim.2008.04.014"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Coccoli P, Esposito P, Cianciaruso B, et al. Hepatitis C and kidney disease. Dig Liver Dis 39 Suppl 1: S83-S85, 2007.","DOI":"10.1016\/S1590-8658(07)80017-X"},{"key":"26","unstructured":"26. Ferri C, Antonelli A, Mascia MT, et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 39 Suppl 1: S13-S21, 2007."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Maya R, Gershwin ME, Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol 34: 85-102, 2008.","DOI":"10.1007\/s12016-007-8013-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Bohan A. History and classification of polymyositis and dermatomyositis. Clin Dermatol 6: 3-8, 1988.","DOI":"10.1016\/0738-081X(88)90044-2"},{"key":"29","unstructured":"29. Cox S, Limaye V, Hill C, Blumbergs P, Roberts-Thomson P. Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis 13: 117-124, 2010."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sultan SM, Isenberg DA. Re-classifying myositis. Rheumatology (Oxford) 49: 831-833, 2010.","DOI":"10.1093\/rheumatology\/kep355"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 2015 Sep 30 (Epub ahead of print).","DOI":"10.1007\/s12016-015-8510-y"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Choy EH, Isenberg DA. Treatment of dermatomyositis and polymyositis. Rheumatology (Oxford) 41: 7-13, 2002.","DOI":"10.1093\/rheumatology\/41.1.7"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Aggarwal R, Oddis CV. Therapeutic advances in myositis. Curr Opin Rheumatol 24: 635-641, 2012.","DOI":"10.1097\/BOR.0b013e328358ac72"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Bronner IM, van der Meulen MF, de Visser M, et al. Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 65: 1456-1461, 2006.","DOI":"10.1136\/ard.2005.045690"},{"key":"35","unstructured":"35. Yang CH, Wu TS, Chiu CT. Chronic hepatitis B reactivation: a word of caution regarding the use of systemic glucocorticosteroid therapy. Br J Dermatol 157: 587-590, 2007."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/14\/56_56.7595\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T12:25:12Z","timestamp":1602505512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/14\/56_56.7595\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":35,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7595","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}